GLPwatch
Trials (2081)
Page 14 of 35.
- A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.
- Liraglutide Effects on Epicardial Fat Inflammatory Genes
- A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis
- Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
- Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight
- Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
- Cognitive Dysfunction and Glucagon-like Peptide-1 Agonists
- Combination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
- Assessment of Safety, Tolerability and Drug Levels of Exenatide Implant
- Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study
- Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes
- SUSTAIN SWITCH: A Research Study to Compare Two Dose Schedules of Semaglutide Taken Once Weekly in People With Type 2 Diabetes
- A Study on How Semaglutide Works on Early Stages of Scar Tissue in the Liver Assessed by Pictures of the Liver
- Preoperative Weight Loss for Open Abdominal Wall Reconstruction
- Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
- Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake
- A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and Pioglitazone,in Subjects With Type 2 Diabetes Treated With Metformin (DURATION - 2)
- Effect of Semaglutide in Patients With Psoriasis and Obesity
- Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
- Safety and Efficacy of Bimagrumab and Semaglutide in Adults Who Are Overweight or Obese
- A Research Study of How Oral Semaglutide Tablets Work in Healthy People Who Are Chinese
- Multi-parametric Imaging of the Knee in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- To Investigate the Blood Concentration of Liraglutide as Well as the Effects on Glucose and Insulin After 21 Days of Daily Subcutaneous Injections of Liraglutide or Placebo
- Nutritional Therapy to Incretin-based Anti-obesity Medications in the Management of Gastrointestinal Adverse Events
- Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
- Investigating How CagriSema, Semaglutide and Cagrilintide Regulate Insulin Effects in the Body of People With Type 2 Diabetes
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
- Ultrasound of the Knee in Obese Patients With Knee Osteoarthritis; Weight Loss
- A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight
- GLP-1 and Non-exercise Activity Thermogenesis in RHZ
- Effects of Dapagliflozin, Semaglutide, and Their Combination in Heart Failure Patients With Prosthetic Heart Valves
- Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes
- Semaglutide 2.4mg for Low Responders After Bariatric Surgery
- Brain Plasticity and GLP-1 Receptor Agonist Treatment for Obesity
- A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver
- Effects of Liraglutide in Chronic Obstructive Pulmonary Disease
- Pharmacogenetics of Response to GLP1R Agonists
- Liraglutide and Insulin Therapy in Patients With Type 2 Diabetes
- The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans
- The POST-ACS Study
- Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
- Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes
- A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
- Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male Subjects
- A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
- Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D
- Multi-Site Trial of Tirzepatide for Smoking Cessation
- 16-week Flexible vs. 8-week Semaglutide Titration
- Semaglutide in Treatment of Obesity
- Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease
- A Study of LY3502970 in Participants With Type 2 Diabetes
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes
- The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians
- Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure
- The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
- Trial of Tirzepatide for the Treatment of Cannabis Use Disorder
- Safety and Efficacy of YH14617 in Diabetes Mellitus
- PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults